other material
confidence high
sentiment neutral
materiality 0.10
Rapport Therapeutics stockholders re-elect three Class I directors and ratify PwC as auditor
Rapport Therapeutics, Inc.
- Reid Huber, Ph.D., John Maraganore, Ph.D., and Wendy B. Young, Ph.D. elected as Class I directors for terms expiring 2028.
- Director votes: Huber 31,146,580 for; Maraganore 31,222,571 for; Young 31,783,990 for.
- Ratification of PricewaterhouseCoopers LLP as independent auditor passed with 32,804,657 votes for, 112,489 against.
- Meeting held June 17, 2025; 36,497,555 shares outstanding and entitled to vote.